Serum creatine phosphokinase elevation in patients treated with intravenous magnesium sulfate

Objective: During the treatment of pre-term labor with magnesium sulfate, we noted an abnormal elevation of maternal serum creatine phosphokinase. This study was aimed at evaluating the relationship between tocolysis with MgSO 4 and maternal serum CPK elevation, which represents the possible damage...

Full description

Saved in:
Bibliographic Details
Published in:International journal of gynecology and obstetrics Vol. 76; no. 3; pp. 257 - 266
Main Authors: Kuno, N, Ishikawa, K
Format: Journal Article
Language:English
Published: Shannon Elsevier Ireland Ltd 01-03-2002
Elsevier Science
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: During the treatment of pre-term labor with magnesium sulfate, we noted an abnormal elevation of maternal serum creatine phosphokinase. This study was aimed at evaluating the relationship between tocolysis with MgSO 4 and maternal serum CPK elevation, which represents the possible damage of muscles by magnesium sulfate. Methods: Clinical records of 45 women treated with magnesium sulfate and beta-sympathomimetics for the treatment of pre-term labor were retrospectively examined. Results: Serum CPK was abnormally elevated in 32 out of 45 cases (71.1%), but in only one out of 21 in the control group. In three cases, the decrease of serum creatine phosphokinase after cessation of magnesium sulfate was demonstrated, despite the continuous infusion of beta-sympathomimetics. Conclusions: Magnesium sulfate may cause muscular damage and abnormal elevation of maternal serum creatine phosphokinase. Special attention must be paid to patients when drugs acting on muscle cells, for example succinyl choline, are going to be used.
ISSN:0020-7292
1879-3479
DOI:10.1016/S0020-7292(01)00582-3